Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
about
Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activityCo-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cellsIdentification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distributionDetection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprosthesesThe tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expressionMatriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivoStimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell linesIn vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cellsmRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissueBasigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblastsTissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cellsMolecular cloning and expression of ps20 growth inhibitor. A novel WAP-type "four-disulfide core" domain protein expressed in smooth muscleCloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domainCharacterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertasesGene expression profiles of the rat cochlea, cochlear nucleus, and inferior colliculus.EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion.Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progressionShedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line.Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.Occurrence of cGMP/nitric oxide-sensitive store-operated calcium entry in fibroblasts and its effect on matrix metalloproteinase secretion.Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell lineIdentification of compounds that inhibit IGF-I signaling in hyperglycemia.Metalloproteinases and tissue inhibitors of metalloproteinases.Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.Overexpression of piRNA pathway genes in epithelial ovarian cancer.Vinculin facilitates cell invasion into three-dimensional collagen matrices.Directed evolution of protease beacons that enable sensitive detection of endogenous MT1-MMP activity in tumor cell lines.Matrix metalloproteases in head and neck cancer.Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cellsTwo distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.Role of myofibroblasts at the invasion front.Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis.Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.Matrix metalloproteinases in tumor invasion: role for cell migration.The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.
P2860
Q22010006-B4EDAFE2-FFD7-4750-99D1-5DF759DEF284Q24311377-D24A5A53-DF70-4A68-8363-5096855801E2Q24317893-A9CDCE78-722D-4981-8F83-22B67C19BC6FQ24338121-8C29AF22-AC56-4B96-B40A-8A8D69089F90Q24654930-DC4342A6-A9F9-4334-B0B0-7A900076F9C6Q24672921-6DC84E2D-40BE-4958-9FF5-64675805412EQ24796519-887A2234-B161-4AE1-9900-B92BA3B1F2D9Q25257233-AB1912B0-9254-42D8-A2F8-5240F65A1606Q27318442-5816D5F2-7FCE-468D-A91D-0420A40AAF22Q28186831-2990227B-4D8C-4E73-BB4D-0EC039A6CDAEQ28216628-683F624C-B5E2-41FA-9420-70CB0641DA1CQ28258413-81F5A982-A6BE-4455-8903-D1188DFEF35CQ28362611-4EDA7F16-E8D9-405A-8E41-924FE01E32D5Q28578517-0DD1155B-E178-4AD0-84B0-35B5CED2465AQ28610368-5A1B6286-C135-4B6F-94C6-319C06B45D78Q28619008-50507A33-3998-41BC-B1B6-2DD8E3388E83Q30473495-CC7F74F1-C7A4-445D-A6DE-9E8B994B98E6Q30539320-E0BCD8D5-F44F-4776-904D-066AA9917DE1Q30955037-C91A42B8-5BF9-438D-B517-5F45D0F412B2Q33179117-8F00A9A0-4CD9-4BE9-8074-42017AC5DFA5Q33233386-B8237ADA-0F2B-4571-AA89-021F776DB74BQ33258695-C653DC44-C2AF-4B8C-859E-E2F05247894AQ33301048-F306B9F0-8B1B-4467-9CE3-A300521E5635Q33527441-FE596A69-E428-44C7-8C26-E0118C88D3F8Q33538435-E0217E88-0AFF-4D6F-8FEF-923137DBDCFBQ33618690-F0B87AA6-7AAF-4F76-AB57-B8F05A67B0F7Q33763496-6327FA38-92C3-4E95-A0EB-B185E0B81BA3Q33800219-5D3B2175-AF40-4FC4-89A8-B19031D47178Q33856620-DDBD1028-0CFD-461C-ABB9-12F618907AA7Q33863220-DDC77339-2F49-435E-A958-55E5DA7F767AQ33886514-33A22716-6E02-414A-AA2B-A8323B4448AAQ33927058-B0E63EB7-5389-45BB-8006-535C58764D44Q33943172-E2E28456-E8DF-4BDB-8272-D61992B21859Q34103424-47EE9C6B-66C0-45D4-8A94-C42812F0AA08Q34584808-6D80F585-8CBE-47D2-8F98-7C660AEB4D44Q34608019-98466FE0-E557-47AB-8DCE-35E277235838Q34616803-34A20D82-5EC4-438E-A303-7BA1C356FEA9Q34657461-C8C08955-746B-4B01-8136-F65E9C028B64Q35012821-195448AF-51AA-48A9-9C93-2536405D97FDQ35137808-5ADC2595-5CE4-4D71-8878-5D07F61B3FE7
P2860
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@ast
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@en
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@nl
type
label
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@ast
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@en
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@nl
prefLabel
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@ast
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@en
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@nl
P2093
P2860
P356
P1476
Membrane-type matrix metallopr ...... and head and neck carcinomas.
@en
P2093
Bellocq JP
Chenard MP
P2860
P304
P356
10.1073/PNAS.92.7.2730
P407
P577
1995-03-01T00:00:00Z